Company intelligence / Profile preview

Reliant Technologies

Mountain View, California, United States

Ownership: Private
Development stage: Other

Overview

Reliant Technologies developed the Fraxel fractional resurfacing laser, which demonstrated safety and efficacy in clinical studies for improving acne scars and was widely adopted by physicians for minimally invasive skin rejuvenation; the technology was commercially successful and set industry standards.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Delphi Ventures (investor)University of California Irvine (clinical trial sponsor/collaborator)

Beyond the preview

Go deeper on Reliant Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reliant Technologies.

Explore the full profile